longbridge

Relmada Therapeutics

RLMD
----

All Shareholders

Shareholder Type

  • Institutions75.04%
  • Hedge funds12.88%
  • VC/PE firms6.42%
  • Individuals & Insiders3.23%
  • Public and others2.43%

Major Shareholders

Major Shareholders Latest
Shareholder
Janus Henderson Group Ltd.
10.47%11.16M0.08%+100.94K
BlackRock, Inc.
6.96%7.43M5.73%+6.14M
Squadron Capital Management LLC
6.89%7.35M1.19%-1.12M
VR Management, LLC
6.42%6.84M1.80%+2.00M
Spruce Street Capital LP
5.99%6.39M0.02%+129.21K
Vanguard Capital Management, LLC
4.87%5.19M1.51%+1.67M
Adage Capital Management, L.P.
4.47%4.76M0.08%+0
Jones Hill Capital LP
3.43%3.66M3.10%+3.31M
OrbiMed Advisors LLC
3.40%3.63M1.09%-1.08M
State Street Investment Management
2.36%2.52M2.02%+2.16M
Geode Capital Management, LLC
2.34%2.49M1.53%+1.64M
Millennium Management LLC
2.21%2.36M1.51%-1.55M
Marshall Wace LLP
2.11%2.25M2.17%-2.23M
Ikarian Capital, LLC
2.01%2.15M0.55%-540.00K
Driehaus Capital Management LLC
2.00%2.13M0.03%+0
Columbia Management Investment Advisers, LLC
1.82%1.94M0.30%+347.03K
Eventide Asset Management, LLC
1.74%1.86M0.94%+1.02M
Balyasny Asset Management L.P.
1.43%1.52M1.18%+1.27M
Sergio TraversaCEO & Director
1.41%1.50M0.19%+200.00K
StemPoint Capital LP
1.37%1.46M0.80%+862.68K
© 2026 Longbridge｜Terms of ServicePrivacy Policy